Kit to determine degree of DNA fragmentation in human sperm; non invasive assay for bladder cancer diagnosis
Total Trials
8
As Lead Sponsor
4
As Collaborator
Total Enrollment
253
NCT00656825
Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers
Phase: Phase 1
Role: Collaborator
Start: Mar 31, 2007
Completion: Jun 30, 2007
NCT00574613
Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis
Phase: Phase 2
Start: Sep 30, 2007
Completion: Sep 30, 2010
NCT00781053
Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study
Start: Jul 31, 2008
Completion: Dec 31, 2010
NCT00975234
Treatment With Autologous Skeletal Myoblasts
Start: May 31, 2009
Completion: Jan 31, 2010
NCT01121731
A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 31, 2010
Completion: Jan 31, 2013
NCT02076763
Observational Study of Acute Intermittent Porphyria Patients
Phase: N/A
Start: Aug 31, 2011
Completion: Feb 28, 2014
NCT01334697
Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers
Start: Nov 30, 2012
Completion: Aug 31, 2013
NCT02082860
Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria
Completion: Nov 30, 2014
Loading map...